2018
DOI: 10.1093/annonc/mdy291.002
|View full text |Cite
|
Sign up to set email alerts
|

Screening for brain metastases (BM) in patients (pts) with stage III non-small cell lung cancer (NSCLC), magnetic resonance imaging (MRI) or dedicated contrast-enhanced computed tomography (dCE-CT)? A prospective observational study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Computed tomography (CT) and magnetic resonance imaging (MRI) are the key modalities for detecting BM. For screening BM, contrast-enhanced (CE) MRI has the advantage of sensitivity over contrast-enhanced CT (CECT) 3,4 ; thus, it is chosen as the first modality. However, MRI has problems with accessibility, and CECT remains an alternative choice for BM screening.…”
mentioning
confidence: 99%
“…Computed tomography (CT) and magnetic resonance imaging (MRI) are the key modalities for detecting BM. For screening BM, contrast-enhanced (CE) MRI has the advantage of sensitivity over contrast-enhanced CT (CECT) 3,4 ; thus, it is chosen as the first modality. However, MRI has problems with accessibility, and CECT remains an alternative choice for BM screening.…”
mentioning
confidence: 99%